Drugs / BGY-1601-VT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06450990 | Jul 2024 → Dec 2025 | bacterial vaginosis, vulvovaginal candidiasis | NEXBIOME THERAPEUTICS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGY-1601-VT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06450990 ↗ |
| Modality | Other / unclassified | “Live biotherapeutic product.” NCT06450990 ↗ |